Newmanbrain 

Pioneering Alzheimer’s Disease and other cognitive diseases early stage screening.

OWNER

Joaquin Gomez-Moya (See Profile)

Sector

Diagnostics

Stage

Prototyping, preclinical

Country

Spain


Early stage cognitive deterioration physiological marker identified.

Pioneering system (fNIRS technique and algorithms) optimized for neurological objective data processing.

Low cost solution for early stage Alzheimer's Disease screening mass market.

This information is confidential, do not share or copy.

Under evaluation at least till: 6th October

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2020 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar